Progenics Pharmaceuticals Inc (PGNX) Return on Assets ROA from the first quarter of 2020 to first quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Progenics Pharmaceuticals Inc  (PGNX)


Progenics Pharmaceuticals Inc's ROA from the first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Progenics Pharmaceuticals Inc's ROA in the first quarter of 2020?
Progenics Pharmaceuticals Inc recorded a cumulative net loss of $-67 million during 12 months ending in the first quarter of 2020, resulting in a negative return on assets (ROA) of -53.23%.

However, within the Healthcare sector 590 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2020 quarter, so far to 4283, from total ROA ranking in the fourth quarter of 2019 at 4732.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Total Assets Change -40.67 % -29.51 % -28.69 % 7.21 % 17.83 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -67 -69 -72 -77 -73
Return On Assets (TTM) -53.23 % -48.27 % -46.58 % -46.24 % -44.21 %
PGNX's Total Ranking # 4283 # 4732 # 4229 # 4288 # 4309
Total Assets (TTM) in million 98 119 130 153 166
Seq. Total Assets Change -17.68 % -8.14 % -14.88 % -7.82 % -2.21 %
Seq. Net Income Change - - - - -

PGNX's 5 Years Annual ROA >> Back to PGNX Management Effectiveness >> Compare PGNX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 269
Sector # 591
Overall # 4133

Return On Assets Statistics
High Average Low
8.19 %
-26.8 %
-56.23 %
(Sep 30 2016)   (Dec 31 2012)





Financial Statements
Progenics Pharmaceuticals Inc's Assets $ 98 million PGNX's Balance sheet
Progenics Pharmaceuticals Inc's Income $ -17 million Quarterly PGNX's Income Statement
PGNX's Income by Division See PGNX's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change -29.51 % 16.13 % -26.65 % 51.61 % -18.5 %
Total Assets in million 119 169 146 199 131
Y / Y Net Income Change - - - - -
Net Income in million -69 -68 -51 11 -39
Annual Return On Assets -57.38 % -39.92 % -34.95 % 5.39 % -29.8 %

PGNX's 5 Years Annual ROA >> Back to PGNX Management Effectiveness >> Compare PGNX ROA to its Competitors



More Return On Assets Ratios
PGNX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PGNX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PGNX's Competitors
Subscribers only: Roa for Progenics Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for PGNX's Customers

You may also want to know
PGNX's Roi PGNX's Inventory Turnover Ratio PGNX's Growth Rates PGNX's Dividend Comparisons
PGNX's Profitability Ratios PGNX's Asset Turnover Ratio PGNX's Dividend Growth
PGNX's Roe PGNX's Valuation Ratios PGNX's Financial Strength Ratios PGNX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:55+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.